Skip to main content

Journal of Cancer Survivorship

Ausgabe 4/2023

Inhalt (27 Artikel)

Open Access

Medical cannabis-related stigma: cancer survivors’ perspectives

Manan M. Nayak, Anna Revette, Peter R Chai, Kristina Lansang, Timothy Sannes, Stephanie Tung, Ilana M. Braun

Open Access COVID-19

How the COVID-19 pandemic has affected eating habits and physical activity in breast cancer survivors: the DianaWeb study

Mattia Acito, Tommaso Rondini, Giuliana Gargano, Massimo Moretti, Milena Villarini, Anna Villarini

Quality of life of patients with rare cancer: a comparison with patients with colorectal cancer and the association with disease trajectory-related factors

Esmee Driehuis, Eline de Heus, Marga Schrieks, Vivian Engelen, Tineke E. Buffart, Geraldine R. Vink, Saskia F. A. Duijts

Quality of care and quality of life as experienced by patients with advanced cancer of a rare tumour type: results of the multicentre observational eQuiPe study

Anouk van Oss, Saskia F. A. Duijts, Hanneke van Laarhoven, Evelien Kuip, Natasja J. H. Raijmakers, Linda Brom

Open Access

Racial disparity in breast cancer survivorship: themes from a series of four national healthcare provider live virtual forums

Jill M. Binkley, Sheryl Gabram, Janae Finley, Dawnovise Fowler, Lisa VanHoose, Lauren E. McCullough

Open Access

Barriers and facilitators for implementation of the SWORD evidence-based psychological intervention for fear of cancer recurrence in three different healthcare settings

Esther Deuning-Smit, Evie E. M. Kolsteren, Linda Kwakkenbos, José A. E. Custers, Rosella P. M. G. Hermens, Judith B. Prins

Open Access

Childhood lymphoma treatment impacts educational outcomes: a registry study from Sweden

Malin Lönnerblad, Reina Suominen, Arja Harila-Saari

Open Access

Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy

T. T. M. Huynh, H. C. D. Aass, R. S. Falk, G. L. Astrup, Å. Helland, T. Bjøro, K. Bjordal, E. Dale, T. P. Hellebust, B. B. Herlofson, E. Malinen, C. E. Kiserud, T. Osnes, C. D. Amdal

Open Access

A multinational investigation of healthcare needs, preferences, and expectations in supportive cancer care: co-creating the LifeChamps digital platform

Rebecca Marshall-McKenna, Grigorios Kotronoulas, Emmanouil Kokoroskos, Andrea Gil Granados, Panagiotis Papachristou, Nikolaos Papachristou, Gonzalo Collantes, Georgios Petridis, Antonis Billis, Panagiotis D. Bamidis

Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire

Marieke van Leeuwen, Jacobien M. Kieffer, Teresa E. Young, Maria Antonietta Annunziata, Volker Arndt, Juan Ignacio Arraras, Didier Autran, Hira Bani Hani, Manas Chakrabarti, Olivier Chinot, Juhee Cho, Rene Aloisio da Costa Vieira, Anne-Sophie Darlington, Philip R. Debruyne, Linda Dirven, Daniela Doege, Yannick Eller, Martin Eichler, Nanna Fridriksdottir, Ioannis Gioulbasanis, Eva Hammerlid, Mieke van Hemelrijck, Silke Hermann, Olga Husson, Michael Jefford, Christoffer Johansen, Trille Kristina Kjaer, Meropi Kontogianni, Pernilla Lagergren, Emma Lidington, Karolina Lisy, Ofir Morag, Andy Nordin, Amal S.H. Al Omari, Andrea Pace, Silvia De Padova, Duska Petranovia, Monica Pinto, John Ramage, Elke Rammant, Jaap Reijneveld, Samantha Serpentini, Sam Sodergren, Vassilios Vassiliou, Irma Verdonck-de Leeuw, Ingvild Vistad, Teresa Young, Neil K. Aaronson, Lonneke V. van de Poll-Franse

Open Access

Future steps in cardio-oncology—a national multidisciplinary survey among healthcare professionals in the Netherlands

Yvonne Koop, Arco J. Teske, Iris Wanders, Hanneke Meijer, J. H. A. M. (Hans) Kaanders, Olivier C. Manintveld, H. Carlijne Hassing, Hester Vermeulen, Angela H. E. M. Maas, Dick-Johan van Spronsen, Femke Atsma, Saloua El Messaoudi

Current pediatric cancer survivorship practices: a report from the Children’s Oncology Group

K. E. Effinger, R. Haardörfer, J. Gilleland Marchak, C. Escoffery, W. Landier, A. Kommajosula, E. Hendershot, K. T. Sadak, D. Eshelman-Kent, K. Kinahan, D. R. Freyer, E. J. Chow, A. C. Mertens

Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors

Andrea C. Betts, Caitlin C. Murphy, L. Aubree Shay, Bijal A. Balasubramanian, Christine Markham, Marlyn Allicock

Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial

Andria R. Morielli, Normand G. Boulé, Nawaid Usmani, Keith Tankel, Kurian Joseph, Diane Severin, Alysa Fairchild, Tirath Nijjar, Kerry S. Courneya

Evolution and growth of the ECHO (Enriching Communication skills for Health professionals in Oncofertility) program: a 5-year study in the training of oncofertility professionals

Jillian Pecoriello, James L. Klosky, Bianca Augusto, Waleska Santiago-Datil, Amani Sampson, Richard Reich, Susan Vadaparampil, Gwendolyn Quinn

The utility of surveillance CT scans in a cohort of survivors of colorectal cancer

Jorja Braden, Prunella Blinman, Ashanya Malalasekera, Kim Kerin-Ayres, Jarrah Spencer, Natalie Southi, Janette L. Vardy

Review

Social adjustment across the lifespan in survivors of pediatric acute lymphoblastic leukemia (ALL): a systematic review

Sara Cho, Courtney Tromburg, Caitlin Forbes, Andrew Tran, Elleine Allapitan, Taryn Fay-McClymont, Kathleen Reynolds, Fiona Schulte

Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcoma

Nina S. Kadan-Lottick, Daniel J. Zheng, Mingjuan Wang, Michael W. Bishop, Deo Kumar Srivastava, Wilhelmenia L. Ross, Rozalyn L. Rodwin, Kirsten K. Ness, Todd M. Gibson, Sheri L. Spunt, Mehmet Fatih Okcu, Wendy M. Leisenring, Leslie L. Robison, Gregory T. Armstrong, Kevin R. Krull

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.